Shine-On BioMedical Co.,Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 9.52 million. Net loss was TWD 37.17 million compared to TWD 19.54 million a year ago.

Basic loss per share from continuing operations was TWD 0.75 compared to TWD 0.43 a year ago. Diluted loss per share from continuing operations was TWD 0.75 compared to TWD 0.43 a year ago.